Survival adjusting for crossover: phase 3 study of ibrutinib vs. chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma

Research paper by Coutre, S, Tedeschi, A, Robak, T, Barr, P. M, Owen, C, Bairey, O, Burger, J, Zhou, et al.

Indexed on: 10 Jun '18Published on: 04 Jun '18Published in: Haematologica

---

Join Sparrho today to stay on top of science

Discover, organise and share research that matters to you

Join for free

Join Sparrho today to stay on top of science

Discover, organise and share research that matters to you

Join for free

---

---

Abstract

Authors: Coutre, S ; Tedeschi ; A ; Robak ; T ; Barr ; P. M ; Owen ; C ; Bairey ; O ; Burger ; J ; Zhou ; C ; Styles ; L ; James ; D. F ; Kipps ; T. J. Article URL: http://www.haematologica.org/cgi/reprint/103/6/e249?rss=1 Citation: Vol 103 No. 6 (2018) pp e249 e251 Publication Date: 2018-06-03T23:55:04-07:00 Journal: Haematologica - the Hematology journal